Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA ...

Nanoparticles that deliver short strands of RNA offer a way to treat cancer and other diseases by shutting off malfunctioning genes. Although this approach has shown some promise, scientists are still ...

病気を引き起こす遺伝子の発現を阻止する新しいツール、RNA干渉(RNAi：RNA interference)は、バイオテクノロジーを使った大々的に売れる新薬の製造に道を開くかもしれない。 しかし、投資家や一般の人たちは同じような予測をこれまで何度も耳にしているため ...

For the first time since we started our surveys in 2003, sixth-ranked Alnylam Pharmaceuticals placed among the top ten small companies. The Cambridge, Mass.-based company develops medicines that rely ...

Silexion Therapeutics Corp (NASDAQ:SLXN) slipped 4% in Tuesday’s premarket session after the biotech firm announced it ...

World RNAi Market 2010Contract service = outsourced research/target validation projects Total = Projected worldwide RNAi revenues for 2010, in US dollars Source: Frost & SullivanScientists hunger for ...